Intracranial Pressure Elevation and MOGAD

Nanthaya Tisavipat; Natthapon Rattanathamsakul; Abdul-Rahman Salman; Laura Cacciaguerra; Sean J Pittock; Eoin P Flanagan; John J Chen

doi:10.1001/jamaneurol.2024.2945

Intracranial Pressure Elevation and MOGAD

JAMA Neurol. 2024 Sep 16;81(11):1226-1228. doi: 10.1001/jamaneurol.2024.2945. Online ahead of print.

Authors

Nanthaya Tisavipat^{1

2}, Natthapon Rattanathamsakul^{3

4}, Abdul-Rahman Salman⁵, Laura Cacciaguerra^{1

2}, Sean J Pittock^{1

2

6}, Eoin P Flanagan^{1

2

6}, John J Chen^{1

2

3}

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, Minnesota.
² Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota.
³ Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
⁵ The George Washington University School of Medicine and Health Sciences, Washington, DC.
⁶ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

PMID: 39283648
PMCID: PMC11406450 (available on 2025-09-16)
DOI: 10.1001/jamaneurol.2024.2945

No abstract available

Plain language summary

This cross-sectional study examines the frequency of increased intracranial pressure and its association with myelin oligodendrocyte glycoprotein antibody-associated disease in patients of various ages.